Revolution Medicines (RVMD) Profit After Tax: 2019-2025
Historic Profit After Tax for Revolution Medicines (RVMD) over the last 7 years, with Sep 2025 value amounting to -$305.2 million.
- Revolution Medicines' Profit After Tax fell 95.28% to -$305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$961.0 million, marking a year-over-year decrease of 69.47%. This contributed to the annual value of -$600.1 million for FY2024, which is 37.52% down from last year.
- Latest data reveals that Revolution Medicines reported Profit After Tax of -$305.2 million as of Q3 2025, which was down 23.17% from -$247.8 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Profit After Tax registered a high of -$37.2 million during Q1 2021, and its lowest value of -$305.2 million during Q3 2025.
- Over the past 3 years, Revolution Medicines' median Profit After Tax value was -$156.3 million (recorded in 2024), while the average stood at -$163.9 million.
- Data for Revolution Medicines' Profit After Tax shows a maximum YoY plummeted of 185.87% (in 2023) over the last 5 years.
- Quarterly analysis of 5 years shows Revolution Medicines' Profit After Tax stood at -$52.7 million in 2021, then fell by 7.27% to -$56.5 million in 2022, then tumbled by 185.87% to -$161.5 million in 2023, then declined by 20.45% to -$194.6 million in 2024, then slumped by 95.28% to -$305.2 million in 2025.
- Its Profit After Tax stands at -$305.2 million for Q3 2025, versus -$247.8 million for Q2 2025 and -$213.4 million for Q1 2025.